T
Tailing Wang
Researcher at China-Japan Friendship Hospital
Publications - 21
Citations - 367
Tailing Wang is an academic researcher from China-Japan Friendship Hospital. The author has contributed to research in topics: Fibrosis & Cirrhosis. The author has an hindex of 11, co-authored 19 publications receiving 323 citations.
Papers
More filters
Journal ArticleDOI
Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B.
Jidong Jia,Jinlin Hou,Huiguo Ding,Guofeng Chen,Qing Xie,Yuming Wang,Minde Zeng,Jingmin Zhao,Tailing Wang,Xiqi Hu,Detlef Schuppan,Detlef Schuppan +11 more
TL;DR: A multicenter study to validate the accuracy of LSM in the assessment of liver fibrosis in a large cohort of Chinese patients with chronic hepatitis B (CHB) is carried out.
Journal ArticleDOI
Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells.
TL;DR: PFD is effective in ameliorating fibrogenesis induced by CCl4 in mice and by the albumin complex in rats, mediated mainly via inhibition of the activation of hepatic stellate cells, as well as antifibrotic actions.
Journal Article
Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
TL;DR: GS and PBLD are abnormally expressed in most HCCs and may be a novel serum marker for early HCC, especially for those patients with low AFP levels (
Journal ArticleDOI
Newly proposed fibrosis staging criterion for assessing carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents.
TL;DR: Staging of hepatic fibrosis in rodents is scientifically rational and repeatable, and is therefore suggested as the criterion for the assessment of experimental hepatic Fibrosis in rodent studies.
Journal ArticleDOI
N‐methyl‐4‐isoleucine cyclosporine attenuates CCl4‐induced liver fibrosis in rats by interacting with cyclophilin B and D
TL;DR: Nim811, a new analogue of cyclosporine A, can inhibit collagen deposition in vitro and reduce liver necrosis in a bile‐duct‐ligation animal model, but whether NIM811 effects on CCl4‐induced rat liver fibrosis, and the related mechanism has not been determined.